Digestive Symptoms in Healthy People and Subjects with Irritable Bowel Syndrome: Validation of Symptom Frequency Questionnaire

Journal of Clinical Gastroenterology

Volumn 49, Issue 7, 2015, Pages e64-e70

  Azpiroz, Fernando ^a,b   Guyonnet, Denis ^c   Donazzolo, Yves ^d   Gendre, David ^e   Tanguy, Jérôme ^c   Guarner, Francisco ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c DANONE RESEARCH   (France)

^d Eurofins Medinet Inc   (Germany)

^e Biorfortis   (France)

Author keywords

digestive symptoms; irritable bowel syndrome; patient reported outcome; quality of life

Indexed keywords

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; BLOATING; BORBORYGMI; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE SEVERITY; FEMALE; FLATULENCE; FOOD AND BENEFITS ASSESSMENT; FUNCTIONAL DIGESTIVE DISORDERS QUALITY OF LIFE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SYMPTOM FREQUENCY QUESTIONNAIRE; VALIDATION STUDY; ADOLESCENT; CLINICAL TRIAL; FRANCE; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; NORMAL HUMAN; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; STANDARDS; STATISTICAL ANALYSIS; SYMPTOM ASSESSMENT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; FRANCE; HEALTHY VOLUNTEERS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; SYMPTOM ASSESSMENT; YOUNG ADULT;

EID: 84937732009     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000178     Document Type: Article

References (25)

1. van Kerkhoven LA, Eikendal T, Laheij RJ, et al. Gastrointestinal symptoms are still common in a general Western population. Neth J Med. 2008;66:18-22.
2. Tielemans MM, Focks JJ, van Rossum LGM, et al. Gastrointestinal symptoms are still prevalent and negatively impact health-related quality of life: a large cross-sectional population based study in The Netherlands. PloS One. 2013;8:e69876.
3. Heaton KW, O'Donnell LJD, Braddon FE, et al. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology. 1992;102: 1962-1967.
4. Drossman DA, Li Z, Andruzzi E, et al. United-states householder survey of functional gastrointestinal disorders: prevalence, sociodemography and health impact. Dig Dis Sci. 1993; 38:1569-1580.
5. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130:1480-1491.
6. Frexinos J, Denis P, Allemand H, et al. Descriptive study of digestive functional symptoms in the French general population. Gastroenterol Clin Biol. 1998;22:785-791.
7. Azpiroz F, Malagelada JR. Abdominal bloating. Gastroenterology. 2005;129:1060-1078.
8. Spiegel BMR, Bolus R, Harris LA, et al. Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice. Aliment Pharmacol Ther. 2010;2:1192-1202.
9. EFSA on dietetic products, nutrition and allergies (NDA); guidance on the scientific requirements for health claims related to gut and immune function. EFSA J. 2011;9:1984.
10. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for Industry: Irritable Bowel Syndrome-Clinical Evaluation of Drugs for Treatment. Rockville Maryland: US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER); 2012.
11. European Medicines Agency. Guideline on the Evaluation of Medicinal Products for the Treatment of Irritable Bowel Syndrome. Draft. CPMP/EWP/785/97 Rev. London: European Medicines Agency; 2013.
12. Spiegel BM, Bolus R, Agarwal N, et al. Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials. Aliment Pharmacol Ther. 2010;32:1275-1291.
13. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395-402.
14. Guyonnet D, Schlumberger A, Mhamdi L, et al. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in a global population of women. A randomised, double-blind, parallel, controlled study. Br J Nutr. 2009;22:1-9.
15. Marteau P, Guyonnet D, Lafaye de Micheaux P, et al. A randomized, double-blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I-2494 in healthy women reporting minor digestive symptoms. Neurogastroenterol Motil. 2013;25:331-e252.
16. Guyonnet D, Chassany O, Picard C, et al. Perceived subject outcomes and impact on health-related quality of life associated with diet using the new Food Benefits Assessment (FBA) questionnaire: development and psychometric validation. Public Health Nutr. 2008;11:1163-1172.
17. Chassany O, Marquis P, Scherrer B, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut. 1999;44:527-533.
18. Spiegel B, Bolus R, Harris LA, et al. Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale. Aliment Pharmacol Ther. 2009;30:1159-1170.
19. Salminen S, van Loveren H. Probiotics and prebiotics: health claim substantiation. Microb Ecol Health Dis. 2012;23:40-42.
20. Fayars PM, Machin D. Quality of Life: Assessment, Analysis and Interpretation. 2nd ed. Chichester, West Sussex: John Wiley & Sons Ltd; 2000.
21. Revicki DA, Wood M, Wiklund I, et al. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998;7:75-82.
22. Talley NJ, Fullerton S, Junghard O, et al. Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol. 2001;96:1998-2004.
23. Guyonnet D, Naliboff B, Rondeau P, et al. Gastrointestinal well-being in subjects reporting mild gastrointestinal discomfort: characteristics and properties of a global assessment measure. Br J Nutr. 2013;110:1263-1271.
24. Pickering GW. The concept of essential hypertension. Ann Intern Med. 1955;43:1153-1160.
25. Mönnikes HJ. Quality of life in patients with irritable bowel syndrome. J Clin Gastroenterol. 2011;45:S98-S101.